Adlai Nortye ANL
NASDAQ ANL
$15.96 +0.31 (+1.98%)
As of: Sep 30, 2026 · 3:58 PM EDT

Adlai Nortye (ANL) Receivables - Other (2022 - 2025)

Updated

Adlai Nortye (ANL) posted Receivables - Other of $907,000 for Q4 2025, up 262.8% from $250,000 a year earlier.

Analysis

Adlai Nortye (ANL) Receivables - Other (2022 - 2025) Analysis & Trends

Since Q4 2022, Adlai Nortye has reported Receivables - Other for 4 quarters.

  • Annual Receivables - Other shows a three-year compound annual growth rate of -80.1% (FY2022 to FY2025).
  • In prior years, Adlai Nortye's Receivables - Other was $250,000 in FY2024 (+11.6%), $224,000 in FY2023 (-99.8%) and $115.74 million in FY2022.
  • The Q4 2025 figure stands as the highest quarterly Receivables - Other since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Adlai Nortye 537.37 Mn 438.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 907,000.00
Dec 31, 2024 250,000.00
Dec 31, 2023 224,000.00
Dec 31, 2022 115.74 Mn
API Access

Adlai Nortye Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ANL&period=max&api_key=YOUR_API_KEY